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Background: A subset of patients receiving first-time permanent pacemakers (PPM) may also benefit from an
implantable cardioverter defibrillator (ICD) based on the presence of left ventricular systolic dysfunction (LVSD).
Routine screening using pocket-sized echocardiography (PSE) may be useful in identifying such patients.
Objective: To determine whether PSE can be used by an inexperienced sonographer to adequately screen for
LVSD in a patient population receiving a first-time PPM.
Methods: A sonographic trainee (medical student) acquired images using PSE, which were then evaluated by an
experienced echocardiologist for both image quality and presence of LVSD. The sensitivity and specificity of
assessment by the inexperienced sonographer was compared to the level 3 echocardiologist.
Results: The patient population included 71 individuals (66% male, mean age 77 ± 12 years). Interpretable images
where left ventricular ejection fraction (LVEF) could be adequately assessed were obtained in 93% of the patient
population. As compared with the echocardiologist, the sonographic trainee had a sensitivity of 60% and a
specificity of 98% in detecting LVSD.
Conclusions: For patients receiving first-time PPM, the use of PSE by a sonographic trainee combined with interpretation
by an experienced imaging cardiologist can triage for the need to perform standard transthoracic echocardiography
(sTTE) by determining the presence of LVSD.
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Permanent pacemakers (PPM) are established therapy for
patients with bradyarrhythmias due predominantly to
sinus node dysfunction or atrioventricular block [1]. The
majority of these patients present with a combination of
symptoms including syncope, pre-syncope, fatigue, palpi-
tations, dyspnea, and exercise intolerance. Clinical assess-
ment including a complete history, physical examination,
and electrocardiogram or other cardiac rhythm monitoring
device usually determines the association between these
symptoms and the underlying conduction abnormality.* Correspondence: cmseifer@sbgh.mb.ca
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unless otherwise stated.Within the population receiving PPM, there is a subset of
patients with structural heart disease who have an under-
lying predisposition to sudden cardiac death (SCD) due to
LVSD that may elude detection by standard clinical assess-
ment. Potential etiologies include coronary artery disease,
dilated cardiomyopathy, hypertrophic cardiomyopathy, ar-
rhythmogenic right ventricular dysplasia, or infiltrative
cardiomyopathy.
The finding of structural heart disease, in particular
LVSD, is pertinent in patients receiving PPM because
these patients may have indications for an implantable
cardioverter defibrillator (ICD) for prevention of ven-
tricular tachyarrhythmia death, in addition to their
pacemaker indication. Several trials have demonstrated
reduced mortality associated with implanting an ICD as
primary prevention against sudden cardiac death in pa-
tients with LVSD in the setting of both ischemic andis is an Open Access article distributed under the terms of the Creative
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practice guidelines recommend ICD implantation for
patients with a left ventricular ejection fraction (LVEF)
of less than 30-5%, despite optimal medical therapy
and, where appropriate, revascularization [4,5].
Although it is reasonable for patients to receive a
standard transthoracic echocardiogram (sTTE) to rule
out structural heart disease in the context of PPM im-
plantation the relatively resource intensive nature of the
sTTE may preclude routine evaluation for all patients
undergoing PPM implantation.
Pocket-sized echocardiography (PSE) is a tool that
can support routine sTTE evaluation [6]. PSE, a minia-
turized version of the sTTE machine, has the capacity
for two-dimensional conventional echocardiography and
color Doppler. Its size confers the advantage of port-
ability, making PSE ideal for point-of-care evaluation,
either at the bedside, or in the outpatient setting. Previ-
ous studies have examined the diagnostic accuracy of
PSE, its potential clinical applications, and the training
involved to maximize safety and effectiveness of its use
[7-11]. Several studies have reported that PSE can
qualitatively assess LVEF with good reliability, even
when a sonographic trainee acquires and/or interprets
images [12-18]. Current recommendations limit the use
of PSE to triaging candidates to receive sTTE evalu-
ation [19].
Although PSE is not currently routinely used prior to
the implantation of PPM, growing interest in its ap-
plication warrants formal evaluation of its use in this
setting. PSE can screen for LVSD in this patient popu-
lation and determine candidacy for sTTE evaluation,
thereby ensuring that all patients undergoing implant-
ation receive the appropriate device. Currently, the
need for, and logistics of, performing PSE on this popu-
lation of patients have yet to be described. This study
aimed to determine if left ventricular systolic function
could be adequately assessed by a sonographic trainee
using PSE, in patients receiving first-time PPM
implantation.
Methods
A prospective study of adult patients undergoing first-time
PPM insertion was conducted at a university-affiliated ter-
tiary care hospital between 2012 and 2013. Patients were
included if they were ≥18 years of age, had an indication
for permanent pacemaker insertion, and consented to par-
ticipate. Informed consent was obtained from all eligible
patients. Exclusion criteria were patients under 18 years of
age, undergoing revision of an existing pacing system,
or unable to provide informed consent. Ethics approval
was granted by the University of Manitoba Biomedical
Research Ethics Board (BREB) [B2012:034] and the St
Boniface Hospital institutional review committee.Training in echocardiography
Prior to recruiting patients for the study, a first-year med-
ical student with no previous background in ultrasound
(i.e., “sonographic trainee”) prepared for one month
in obtaining and interpreting echocardiographic images.
Visual estimations of LVEF on PSE were compared to the
LVEF quantitatively determined using biplane Simpson’s
on sTTE. During the training period, a total of 80 scans
were completed with both PSE and sTTE. The sono-
graphic trainee also interpreted an additional 150 images
previously assessed by a level 3 echocardiologist to im-
prove accuracy of visual estimation of LVEF.
Image and data acquisition
Patients were approached by the sonographic trainee in
the pre- and post-cardiac procedure area within two
hours of PPM implantation. Immediately after providing
informed consent, patients were scanned by the sono-
graphic trainee with PSE. Video loops of parasternal
long- and short-axes, apical four- and two-chamber, and
subcostal views were obtained and digitally recorded on
the PSE device. Relevant medical history was obtained
from the patient, hospital charts, and procedural notes.
Assessment of LVEF
Promptly following PSE scanning, the recorded video
loops were reviewed by the sonographic trainee and a
cardiologist with level 3 competency in echocardiog-
raphy, and assessed qualitatively for image quality and
LVEF. Figure 1 shows an example of the comparison of
images acquired using sTTE and PSE on the same pa-
tient. Each interpreter was blinded to the other. Overall
LVEF was graded by visual estimation as being normal
(≥50%), mildly reduced (40-49%), moderately reduced
(30-39%), or severely reduced (<30%). If a significantly
reduced LVEF (defined as <40%) was found, the patient
was subsequently considered for evaluation with sTTE.
If this sTTE examination was consistent with LVSD, the
cardiologist implanting the pacemaker was informed.
Statistical analysis
Statistical analysis was performed with GraphPad Prism 6
(GraphPad Software, Inc., San Diego, CA). Data are pre-
sented as percentages and the mean ± SD. The Cohen’s
kappa coefficient was used to measure inter-observer con-
cordance for categorical variables, with confidence inter-
vals of 95%. The chi-squared test was used to calculate
sensitivity, specificity, positive predictive value, and nega-
tive predictive values accordingly.
Results
Study population
Of the 75 eligible patients, 71 were enrolled in the study.
Four patients were excluded because they declined to
Figure 1 Comparison of images acquired using (a) sTTE and (b) PSE on the same patient.
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line clinical characteristics of the study population are
summarized in Table 1. The mean age was 77 ± 12 years
and 66% were male. Of the total study population,
27 (38%) received a PPM due to sinus node dysfunction,
30 (42%) due to second or third degree atrioventricular
block, and 14 (20%) due to a combination of sinus and
atrioventricular node dysfunction. Twenty-three patients
(32%) were referred for PPM implantation as outpa-
tients, while 48 (68%) were referred from an inpatient
unit. The prevalence of presenting symptoms is summa-
rized in Table 2.Table 1 Baseline clinical characteristics of the study
population (n = 71)
Characteristic n (%)
Age (years) ± SD 77 ± 12
Male 47 (66)
Indication for PPM implantation
Sinus node dysfunction (SND) 27 (38)
Atrioventricular nodal block (AVB) 30 (42)
Both SND and AVB 14 (20)
Atrial fibrillation 28 (39)
Smoking history (>10 pack years) 28 (39)
Hypertension 52 (73)
Diabetes mellitus type 2 16 (23)
Dyslipidemia 22 (31)
Coronary artery disease 20 (28)
Previous myocardial infarction 19 (27)
Previous stroke or transient ischemic attack 13 (18)
History of congestive heart failure 15 (21)PSE image acquisition and interpretation
PSE video clips were obtained and recorded for all en-
rolled participants. The mean time required to perform
the scan was 5.8 ± 2.6 minutes (range: 2–15 minutes).
Image quality was assessed as “good” in 40%, “fair” in
51%, and “poor” in 9%. Overall, LVEF could be reliably
assessed from PSE images in 66 of the 71 patients (93%).
The distribution of LVEF in the study population as
assessed by PSE is summarized in Table 3. Of these in-
terpretable images, there was 91% concordance between
the sonographic trainee and echocardiologist in the as-
sessment of LVEF, with a linearly weighted Cohen kappa
value for inter-observer concordance of 0.725 ± 0.112
(95% CI 0.505-0.945). As compared to the echocardiolo-
gist, LVEF was overestimated in 5% and underestimated
in 5% by the sonographic trainee. The inter-observer
concordance between the sonographic trainee and echo-
cardiologist was 96% for the ability to assess presence or
absence of LVSD. (Table 4) Conversely, the sonographic
trainee falsely identified the presence of LVSD in one
(2%) scan, while missing the presence of LVSD in two
(3%) scans. The kappa value for inter-observer variabilityTable 2 Symptoms at initial patient presentation to
health care centre (n = 71)








Table 3 LV ejection fraction based on estimation of PSE
images (n = 71)




Normal (>50%) 60 (85%) 58 (82%)
Mild dysfunction (40-50%) 6 (8%) 3 (4%)
Moderate dysfunction (30-40%) 2 (3%) 2 (3%)
Severe dysfunction (<30%) 2 (3%) 3 (4%)
Uninterpretable 1 (1%) 5 (7%)
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0.247-1.0). The sensitivity and specificity of the sono-
graphic trainee’s evaluation compared to the cardiologist’s
evaluation for LVSD was 60% and 98%, respectively.
Accuracy of PSE compared to sTTE
Of the total study population, 28 patients (39%) received
a sTTE for a clinical indication within 12 months of in-
clusion in this study. We took this opportunity to com-
pare these images with those obtained by PSE. Of these
patients, 2 (7%) had PSE exams that were not interpret-
able. For the remaining 26 patients, the accuracy of
LVEF estimation by PSE as compared to sTTE was 96%
for the echocardiologist and 88% for the sonographic
trainee. The echocardiologist correctly assessed 100% of
patients for the presence or absence of LVSD (LVEF ei-
ther greater or less than 40%) using PSE images, whereas
the sonographic trainee correctly assessed 96%.
Discussion
With advancements in cardiovascular imaging, it is
tempting to seek out new clinical applications to justify
new technology. While individual patients may benefit
from increased access to diagnostic tools, formal evalu-
ation of the overall feasibility of this tool is necessary
prior to routine institution. The results of this study sug-
gest that PSE can identify patients receiving first-time
PPM at risk of SCD due to LVSD.
The use of the PSE to visualize left ventricular wall mo-
tion and systolic function has been previously evaluated.
Several studies have demonstrated that the PSE can obtain
interpretable images in the vast majority (85-100%) of pa-
tients by inexperienced sonographers, in both the in-
patient and outpatient settings [10-12]. A complete sTTE
study takes approximately 20–25 minutes to acquire, withTable 4 Assessment of PSE images for presence or absence o
echocardiologist (n = 66)
Sonographic trainee interpretation LVSD absent (LVEF > 40%)
LVSD present (LVEF < 40%)a standard echocardiography machine costing approxi-
mately four times that of a PSE machine [20]. The present
study demonstrated that the feasibility (94% of images
were interpretable) and speed (average time to scan of
6 minutes) of PSE image acquisition were suitable for pre-
implant echocardiographic evaluation.
Previous studies comparing images acquired by an in-
experienced sonographer (e.g., medical resident) versus
an experienced sonographer (e.g., cardiologist with level
3 competency in echocardiography) have shown that
there is good correlation between PSE and sTTE for the
assessment of LVEF [12-18]. High inter-observer correl-
ation between the trainee and the imaging cardiologist is
important in order to appropriately triage patients for
sTTE in the setting of pre-PPM implantation. This study
found good concordance (κ = 0.725) in categorizing
LVEF into normal, mildly reduced, moderately reduced,
and severely reduced. This was similar to the concord-
ance (κ = 0.606) rate described by Panoulas and col-
leagues, although in their study medical students and
the cardiologist evaluated separately acquired images
[18]. Compared to the evaluation by the echocardiolo-
gist, the sonographic trainee had a good specificity
(98%) but a poor sensitivity (60%), reflecting a ten-
dency to “over-call” LVSD. This suggests that a sono-
graphic trainee can assess PSE images for LVSD with
good concordance compared with an echocardiologist
in order to triage candidates for a more sensitive sTTE
evaluation.
PSE studies show that the strength of correlation with
sTTE is dependent upon level of training in echocar-
diography, which differ depending on patient setting
[15-18,21]. No studies have examined the accuracy of
PSE in a pre-PPM implant setting. Although this study
did not formally compare PSE directly with sTTE, 28 of
the 71 patients underwent sTTE as part of their clinical
assessment. LVEF as estimated from PSE images by the
echocardiologist compared to sTTE were concordant in
96% of these 28 patients. As expected, the sonographic
trainee was slightly less accurate in describing LVEF
from PSE images, with 88% concordance. There was
greater success in detecting LVSD than estimating LVEF;
the echocardiologist was able to identify the presence or
absence of LVSD in all (100%) patients, and the sono-
graphic trainee was able to do so in all but one patient
(96%). Overall, the evaluation of LVEF with PSE in thef significant LVSD by sonographic trainee vs.
Echocardiologist evaluation
LVSD absent (LVEF > 40%) LVSD present (LVEF < 40%)
60 (91%) 2 (3%)
1 (1%) 3 (5%)
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sTTE in this subgroup of patients.
This study provides insight into how PSE may be im-
plemented into the pre-procedural assessment prior to
the insertion of a PPM. There are few published studies
describing the pre-procedural or pre-operative role of
PSE. Frederiksen and colleagues demonstrated that PSE
can be used for pre-operative assessment for day surgery
patients and determined that the parasternal long axis
view alone, taken with the patient in a sitting position,
suffices to estimate LVEF [7]. In contrast, all participants
in this study were scanned with PSE in a supine position,
which enabled a comprehensive echocardiographic exam
amenable to enhancing maneuvers, such as lying in the
left lateral decubitus position.Limitations and future directions
This study presented several limitations. First, as a pilot
study, the number of patients included was small, and ac-
cordingly, was not intended to affect clinical management
of patients undergoing PPM implantation who were en-
rolled as participants. Although the cardiologist implanting
the pacemaker was notified of the presence of possible
LVSD on PSE, a protocol for management of LVSD found
on PSE was not formally instituted. Although this study
commented on the accuracy of PSE compared to sTTE in
a subset of patients, this was not the primary objective.
Image accuracy has been previously well described in vari-
ous other patient populations [7-18]. Finally, although this
study validated the use of PSE in assessing LVEF, if more
extensive information on cardiac structure and function is
required clinically prior to PPM implantation sTTE is su-
perior to that of PSE. For example, other cardiomyopathies
including hypertrophic cardiomyopathy, noncompaction
of the left ventricle, and arrhythmogenic right ventricular
dysplasia may present with bradyarrhythmias and a high
risk of SCD due to tachyarrhythmias. It follows that there
are limitations in training a sonographer only to interpret
LVEF; broader training with PSE in other aspects of echo-
cardiography may be important to provide more extensive
use of this technology.Conclusions
PSE is a bedside tool that can effectively screen for LVSD
in patients undergoing PPM. An inexperienced sono-
graphic trainee can learn to acquire images quickly and
accurately resulting in minimal disruption of the existing
pre-procedure workflow. This technology may assist in
identifying patients who require more complex cardiac
implantable electronic devices.
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